Dual-Enzyme Composition for Alcohol Metabolism
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for managing alcohol-induced veisalgia and related symptoms are inadequate, particularly for casual and frequent drinkers, as they often involve toxic over-the-counter pain relievers and lack effective, safe, and convenient preventive measures for alcohol metabolism, with no medication approved for acute alcohol intoxication.
Innovation Solution
A dual-enzyme composition comprising Alcohol Dehydrogenase and Aldehyde Dehydrogenase in a specific molar ratio (1:3 to 1:51) sourced from animal livers or Baker's yeast, administered orally or in enteric capsule form to enhance alcohol breakdown and prevent veisalgia by converting ethanol to acetaldehyde and subsequently to acetate, thereby reducing toxic metabolite accumulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If over-the-counter pain relievers like aspirin or acetaminophen are used to relieve veisalgia, then symptom relief is achieved, but liver toxicity occurs
Solution Approach 1:
The invention converts the harmful accumulation of acetaldehyde (which causes veisalgia) into a beneficial process by enhancing its metabolism through ALDH enzyme supplementation. Instead of masking symptoms with toxic pain relievers, the invention addresses the root cause by promoting the conversion of toxic acetaldehyde into less harmful acetate, thereby relieving symptoms without liver toxicity.
Solution Approach 2:
The invention introduces exogenous ALDH enzyme as an intermediary substance that mediates the metabolism of acetaldehyde. This intermediary enzyme accelerates the conversion of acetaldehyde to acetate, providing a safe pathway to eliminate the toxic substance without requiring toxic pain relievers.
2Reliability
If Haemodialysis is used for acute alcohol intoxication, then life-saving effect is achieved, but it is not available as a routine treatment option
Solution Approach 1:
The invention uses oral enzyme supplements (ALDH and ADH) as a disposable, easy-to-administer alternative to complex haemodialysis machinery. These enzyme capsules provide rapid alcohol metabolism enhancement without requiring hospital infrastructure, making life-saving treatment available as a routine over-the-counter option.
Solution Approach 2:
The invention replaces the mechanical haemodialysis system with a biochemical solution using oral enzyme supplements. Instead of using machines to physically filter alcohol from blood, the invention uses enzymatic catalysis to chemically accelerate alcohol metabolism in the body, achieving the same life-saving effect through a simpler, more accessible method.
3Productivity
If ADH and ALDH enzymes are used in improper ratios, then alcohol breakdown is enhanced, but local elevation of acetaldehyde occurs causing veisalgia
Solution Approach 1:
The invention optimizes the ratio parameter of ADH to ALDH enzymes (specifically 1:3 to 1:51) to balance the two-stage metabolism process. By carefully controlling this parameter, the invention ensures that acetaldehyde is produced and consumed at matched rates, preventing accumulation while maintaining high alcohol breakdown efficiency.
Solution Approach 2:
The invention creates a feedback-balanced enzymatic system where the output of the first enzyme (ADH producing acetaldehyde) is matched by the capacity of the second enzyme (ALDH consuming acetaldehyde). This feedback balance prevents intermediate substance accumulation by ensuring each stage's output matches the next stage's input capacity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dual-enzyme composition effectively reduces veisalgia symptoms and metabolic harm by efficiently breaking down alcohol and its by-products, providing significant relief in surveys and demonstrating stability across various molar ratios, with potential for emergency use in acute intoxication scenarios.
Implementation Method 1
The main pathway of ethanol metabolism involves its oxidation to acetaldehyde, a reaction that is catalysed by ADH and co-enzyme NAD+
Implementation Method 2
In a second reaction catalyzed by ALDH and co-enzyme NAD+, acetaldehyde is oxidized to acetic acid
Implementation Method 3
a first enzyme of the two exogenous enzymes is capable of converting alcohol into a first metabolite while a second enzyme thereof is capable of converting the first metabolite into a second metabolite
Data Source
AI summary
A composition includes two exogenous enzymes from animals for consumption by human beings to prevent, treat and/or alleviate veisalgia and/or symptoms associated therewith arising from or caused by consumption or spontaneous production of alcohol through a dual-enzyme based breakdown of the alcohol, wherein a first enzyme of the two exogenous enzymes is capable of converting alcohol into a first metabolite while a second enzyme thereof is capable of converting the first metabolite into a second metabolite which is excretable to systemic circulation after an oxidation reaction of the alcohol in the presence of the two exogenous enzymes and NAD+/NADH, and wherein the first enzyme to the second enzyme is in a molar ratio of 1:3-51 in the composition in order to avoid an elevation in the level of the first metabolite in the human being.